Drug intelligence / Profile preview

68Ga-PSMA-0057

Development stage
Unknown
Lead developer
Chengdu StarRay Therapeutics
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

68Ga-PSMA-0057 is a radiopharmaceutical imaging agent developed by Chengdu StarRay Therapeutics for the visualization of prostate-specific membrane antigen (PSMA) expression in patients with prostate cancer, particularly metastatic castration-resistant prostate cancer (mCRPC). It comprises a targeting ligand specific for PSMA labeled with the positron-emitting radioisotope Gallium-68 (68Ga). Upon intravenous administration, the agent binds to PSMA-expressing tumor cells, enabling high-sensitivity detection of primary and metastatic lesions via Positron Emission Tomography (PET) imaging. This agent is utilized as part of a theranostic strategy to identify patients suitable for targeted radioligand therapy with 177Lu-PSMA-0057, ensuring that the therapeutic agent is delivered to tumors with confirmed target expression.

Other names
Gallium [68Ga] PSMA-0057 InjectionGallium-68 PSMA-0057Gallium68 PSMA-0057Gallium 68 PSMA-0057
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on 68Ga-PSMA-0057.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-PSMA-0057.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call